Old Web
English
Sign In
Acemap
>
authorDetail
>
Jennifer Ashley Ezzell
Jennifer Ashley Ezzell
University of North Carolina at Chapel Hill
Pathology
Medicine
metastatic melanoma
Pembrolizumab
Cancer research
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
High intratumoral tryptophan metabolism is a poor predictor of response to pembrolizumab (pembro) in metastatic melanoma (MM): Results from a prospective trial using baseline C11-labeled alpha-methyl tryptophan (C11-AMT) PET imaging for response prediction.
2020
Journal of Clinical Oncology
Jorge D. Oldan
David W. Ollila
Ben Giglio
Eric P. Smith
Deeanna M. Bouchard
Marija Ivanovic
Yueh Z. Lee
Frances A. Collichio
Michael O. Meyers
Diana E. Wallack
Amir H. Khandani
Amber Abernathy-Leinwand
Patricia K. Long
Jennifer Ashley Ezzell
Dimitri G. Trembath
Zibo Li
Terence Z. Wong
Stergios J. Moschos
Show All
Source
Cite
Save
Citations (0)
Expression of tryptophan metabolizing enzymes (TMEs) and its transporter, LAT1, in metastatic melanoma (MM): Prognostic and therapeutic implications.
2019
Journal of Clinical Oncology
Dimitri G. Trembath
Paul B. Googe
Jill S. Frank
Madeline H Kowalski
Marcus Spearman
Taylor Marie Lagler
Jennifer Ashley Ezzell
Nancy E. Thomas
David W. Ollila
Stergios J. Moschos
Show All
Source
Cite
Save
Citations (0)
1